


Our People Third Rock Ventures























Back to all profiles











Kevin Starr
Partner
Kevin Starr is a co-founder of Third Rock Ventures with more than 25 years of experience building and leading biotechnology companies. Kevin’s focus has been on the formation, development and strategic governance of our portfolio companies. He has been actively identifying and evaluating new investments for our first three funds, where he also helped successfully raise $1.3 billion for Third Rock. Kevin contributes as an advisor to our Fund IV portfolio companies and will continue to play active board roles in our current Fund I, II and III portfolio companies. In many of these companies, Kevin functioned as chief executive officer through the first 12-18 months after launch. His portfolio company roles include:

Chairman of the board and former interim chief executive officer of Decibel Therapeutics 
Board member of MyoKardia
Board member of PanOptica
Chairman of the board and former interim chief executive officer of Sage Therapeutics
Former board member and interim chief executive officer of Agios Pharmaceuticals
Former board member of Global Blood Therapeutics
Former board member and interim chief executive officer of Afferent Pharmaceuticals
Former board member and interim chief executive officer of Zafgen Pharmaceuticals

Prior to Third Rock, Kevin served as chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he helped raise billions of dollars in capital through strategic alliances and public financing and drove the company’s growth through organic expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals. Kevin holds an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.
Kevin is a founding investor in Prospect Pictures, which produced the hit Broadway show turned movie "Rock of Ages." 

Administrative Support
Linda HeathExecutive Assistant lheath@thirdrockventures.com (617) 585-2049
Associated Portfolio Companies



















Partners







Alexis Borisy
Partner







Abbie Celniker, Ph.D.
Partner







Neil Exter
Partner







Kevin Gillis
Partner/Chief Financial Officer







Charles Homcy, M.D.
Partner







Sarah Larson
Partner/Chief Human Resources Officer







Mark Levin
Partner







Craig Muir
Partner/Chief Technology Officer







Cary Pfeffer, M.D.
Partner







Kevin Starr
Partner







Robert Tepper, M.D.
Partner










Venture Partners







Frank T. Gentile, Ph.D.
Venture Partner







Mark A. Goldsmith, M.D., Ph.D.
Venture Partner







Perry Karsen
Venture Partner







Christoph Lengauer, Ph.D.
Venture Partner







Philip Reilly, M.D., J.D.
Venture Partner







Stephen Sherwin, M.D.
Venture Partner







Jeffrey Tong, Ph.D.
Venture Partner







Barbara Weber, M.D.
Venture Partner










Entrepreneurs-In-Residence







Jason Coloma, Ph.D.
Entrepreneur-in-Residence







Keith Dionne
Entrepreneur-in-Residence







Jeffrey Finer, M.D., Ph.D.
Entrepreneur-in-Residence







Brian Jones, Ph.D.
Entrepreneur-in-Residence







Robert Kamen, Ph.D.
Entrepreneur-in-Residence







Leon Murphy, Ph.D.
Entrepreneur-in-Residence







Glenn Pierce, M.D., Ph.D.
Entrepreneur-in-Residence







Laurence Turka, M.D.
Entrepreneur-in-Residence










Domain Experts







Karina Chmielewski
Senior Director, Platform Operations







Dina Ciarimboli
General Counsel 







Cynthia Clayton
Head of Communications







John Keilty
General Manager, Platform Operations










Principals and Associates







Brian Albrecht, Ph.D.
Principal







Tim Funnell, DPhil.
Principal







Melissa McCracken, Ph.D.
Associate







Travis Murdoch, M.D.
Principal







Vyas Ramanan, Ph.D.
Associate







Dominique Verhelle, Ph.D., M.B.A.
Principal










Finance & Accounting







Alison Connors, C.P.A.
Controller







Scott Frechette, C.P.A.
Staff Accountant







Ivan Hyep
SENIOR FINANCE MANAGER







Greg McGraw
Accounting Manager 







Jessica Schoenig, C.P.A.
STAFF ACCOUNTANT










Recruiting







Andrea DiMella
Recruiting Director







Tracy Nicholson
Recruiting Director







Chris Robinson
Vice President, Recruiting










Administrative







Zoe Angell
Executive Assistant







Megan Graziano
Manager of Operations and Administration







Linda Heath
Executive Assistant







Marcia Hemphill
Office Manager - West Coast and Executive Assistant







Rhea Kappa
Receptionist/Administrative Assistant







Laura Vitale
Administrative Assistant







Maribel Laboy
Executive Assistant







Ian Miller
Administrative Assistant 







Corey O’Keeffe
Event Planner & Communications







Angelo Severino
Executive Assistant







Tracy Williams
Executive Assistant










At Third Rock, people are our most valuable asset
Check our Careers page to learn about career opportunities within the Third Rock portfolio
Third Rock Careers












Copyright © 2017 Third Rock Ventures, LLC. All Rights Reserved.



Terms of Use
Privacy Policy




Terms of Use
Privacy Policy















   Kevin Starr | Millennium Pharmaceuticals , Inc. | ZoomInfo.com











Kevin P. Starr - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Kevin P. Starr
Board Member at Alnylam Pharmaceuticals, Inc.


View Full Profile
Are you Kevin P. Starr? Claim your profile


 


Sign up for Equilar Atlas and view Kevin P. Starr's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Kevin P. Starr's  network and community.
												FOLLOW changes in Kevin P. Starr's employment and money-in-motion.
												CONNECT with Kevin P. Starr through your network of contacts.
												








Kevin P. Starr's Executive Work History


Current


Board Member, 
Alnylam Pharmaceuticals, Inc.


Board Member, 
MyoKardia, Inc.


Board Member, 
Sage Therapeutics, Inc.


Past
To view Kevin P. Starr's complete executive work history, sign up now
Education


														 B.A., 
															Colby College


														 M.S., 
															Boston College


Age
54

 
 


Kevin P. Starr's Biography



Kevin P. Starr. Mr. Starr has served as a member of our Board of Directors since September 2011. From October 2011 to August 2013, he also served as our interim Chief Executive Officer. In 2007, Mr. Starr co-founded Third Rock Ventures, a venture capital firm where he remains a partner. Mr. Starr served as the interim Chief Executive Officer of Decibel Therapeutics from October 2015 to July 2016. From 2003 to 2007, Mr. Starr undertook a number of entrepreneurial endeavors in the life science and entertainment industries. From 2001 to 2002, Mr. Starr served as chief operating officer of Millennium Pharmaceuticals, Inc. He also served as Millen ...
(Read More)

			Kevin P. Starr. Mr. Starr has served as a member of our Board of Directors since September 2011. From October 2011 to August 2013, he also served as our interim Chief Executive Officer. In 2007, Mr. Starr co-founded Third Rock Ventures, a venture capital firm where he remains a partner. Mr. Starr served as the interim Chief Executive Officer of Decibel Therapeutics from October 2015 to July 2016. From 2003 to 2007, Mr. Starr undertook a number of entrepreneurial endeavors in the life science and entertainment industries. From 2001 to 2002, Mr. Starr served as chief operating officer of Millennium Pharmaceuticals, Inc. He also served as Millennium's chief financial officer from 1998 to 2002. Mr. Starr currently serves on the board of directors of Alnylam Pharmaceuticals, Inc., PanOptica, Inc., Decibel Therapeutics, Inc. and MyoKardia, Inc. Mr. Starr received an M.S. in corporate finance from Boston College and a B.S./B.A. in mathematics and business from Colby College. Mr. Starr's qualifications to serve on our Board of Directors include his executive management roles with responsibility over key financial and business planning functions and experience in the formation, development and business strategy of multiple start-up companies in the life sciences sector.
		
Source: Sage Therapeutics, Inc. on 03/17/2017
		
	

 






Sign up for Equilar Atlas and view Kevin P. Starr's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Kevin P. Starr. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Kevin P. Starr's  network and community.
												FOLLOW changes in Kevin P. Starr's employment and money-in-motion.
												CONNECT with Kevin P. Starr through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Kevin P. Starr


















Kevin P. Starr's Connections (134)





Sign up now to view Kevin P. Starr's 134 connections »









Steven M. Paul
Dir., President and Chief Executive Officer, Voyager Therapeutics, Inc.









John L. LaMattina
Board Member, Zafgen, Inc.









Marc Tessier-Lavigne
Scientific Advisor, Agios Pharmaceuticals, Inc.









Raju S. Kucherlapati
Former Board Member, AVEO Pharmaceuticals, Inc.









Kimberly J. Popovits
Chairman of the Board, President and Chief Executive Officer, Genomic Health, Inc.









Mark L. Perry
Board Member, NVIDIA Corporation









Colin Goddard
Former Chief Executive Officer, OSI Pharmaceuticals









John K. Clarke
Former Board Member, Alnylam Pharmaceuticals, Inc.









Edward D. Miller
Former Board Member, NantHealth, Inc.









Victor J. Dzau
Former Board Member, Medtronic plc








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993















Kevin Starr, Third Rock Ventures LLC: Profile & Biography - Bloomberg


































































  


































Feedback





Kevin Starr

Partner/Co-Founder,
Third Rock Ventures LLC






Career History




Partner/Co-Founder
Third Rock Ventures LLC, 4/2007-PRESENT


Chairman
Afferent Pharmaceuticals Inc, PRESENT


Founding Investor
Prospect Pictures Ltd, PRESENT


Interim CEO
Ember Therapeutics, PRESENT


Chairman/Interim CEO
Decibel Therapeutics, 10/2015-7/2016


Interim CEO
Sage Therapeutics Inc, 9/2011-8/2013


Interim CEO
Sterogen Biopharma Inc, 1/2011-9/2011


CFO/COO
Millennium Pharmaceuticals Inc, 12/2001-12/2002


Exec VP:Business Ops/CFO
Millennium Pharmaceuticals Inc, 6/2001-12/2001


Chief Financial Officer
Millennium Pharmaceuticals Inc, 12/1998-6/2001


VP:Finance
Millennium Biotherapeutics Inc, 3/1998-12/1998


Manager/Controller
Biogen Idec Inc, 1991-4/1998


Interim CEO
Agios Pharmaceuticals Inc, 6/2008-UNKNOWN


Co-Founder
Third Rock Ventures LLC, 4/2007-UNKNOWN



Digital Equipment Corp, FORMER


Interim CEO
Zafgen Inc, FORMER


Interim CEO
Afferent Pharmaceuticals Inc, FORMER


Show More









Website:
www.thirdrockventures.com






Corporate Information
Address:

29 Newbury Street
3rd Floor
Boston, MA 02116
United States


Phone:
1-617-585-2000


Fax:
1-617-859-2891


Web url:
www.thirdrockventures.com











From The Web












Personal Information



Education



Boston College
Master's Degree, Finance


Colby College
Bachelor's Degree








Memberships



Board Memberships




Afferent Pharmaceuticals Inc


Chairman, PRESENT




Prospect Pictures Ltd


Board Member, PRESENT




Panoptica Inc


Board Member, PRESENT




Ember Therapeutics


Board Member, PRESENT




Sage Therapeutics Inc


Chairman, PRESENT




Alnylam Pharmaceuticals Inc


Board Member, PRESENT




Decibel Therapeutics


Chairman, PRESENT




Myokardia Inc


Board Member, 6/2012-PRESENT




Global Blood Therapeutics Inc


Board Member, 5/2012-2/2016




Zafgen Inc


Board Member, 12/2006-12/2015




Agios Pharmaceuticals Inc


Chairman, UNKNOWN-6/2015




Sterogen Biopharma Inc


Board Member, 9/2011-9/2011




Human Genome Sciences Inc


Board Member, 10/2006-8/2007




Konarka Technologies Inc


Board Member, FORMER




Vitae Pharmaceuticals Inc


Board Member, FORMER




Cambridge Savings Bank


Board Member, FORMER




Sage Therapeutics Inc


Board Member, 9/2011-UNKNOWN




Agios Pharmaceuticals Inc


Board Member, 6/2008-UNKNOWN



Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data



































Kevin P Starr - Mashpee, MA | Intelius



























Sign In



We found Kevin P Starr in Mashpee, MA


Kevin P Starr

                                                                           Intelius found that Kevin P Starr  is  a male between 50 and 60 years old from Mashpee, MA.  We have connected them to
                20 addresses,
                14 phones,
                and 2 relatives or associates.
         





Also Known As

Kevin D Starr


Get Report Now

Age

Kevin P Starr is in his 50s

Kevin Has Lived In

Mashpee, MA
Boston, MA
Osterville, MA

Kevin's Relatives

Mary Starr
Daire Starr







Kevin P Starr



Zodiac SignLibra



GenderMale



Professional Status
Committee Member at Alnylam Pharmaceuticals , Inc.



Get Report Now










Want to know more about Kevin? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Kevin, or use our people search engine to find others.
Get Background Check on Kevin P Starr
Get a Criminal Check on Kevin P Starr
Get a Public Record Report on Kevin P Starr
Get a People Search Report on Kevin P Starr


Kevin P Starr's Contact Information
Known Cities Lived In
Find out where Kevin P Starr has lived as well as Kevin P Starr's phone numbers and email addresses.




Kevin P Starr Has Lived in 2 States
Massachusetts Address for Kevin P Starr


219 D******* R* 

Mashpee, MA


Has Lived In

Mashpee, MA
Boston, MA


Get Full Address Report










Phone Numbers Associated with Kevin P Starr

(508) ***-**** - Mashpee, MA 
(617) ***-**** - Cambridge, MA 
(617) ***-**** - Boston, MA 


Get Full Phone Report



Email Addresses Associated with Kevin P Starr

k****r@***.com
k****r@***.com
k*********r@***.com


Get Email Report




Kevin P Starr's Education Information
Known Schools Attended
Learn about Kevin P Starr's academic history.  Find out which schools Kevin P Starr attended, the dates attended as well as the degrees Kevin P Starr received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Kevin P Starr Has Attended 7 Schools
Boston College - Wallace E. Carroll Graduate School of Management Kevin P Starr has a Msf in Finance               
Boston College - Wallace E. Carroll Graduate School of Management                              Kevin P Starr has a Msf, in Finance               
Boston College - Wallace E. Carroll Graduate School of Management               1987               Kevin P Starr has a Msf, Finance in Finance               
Colby College               1980 – 1984               Kevin P Starr has a Bs/ba in Mathematics, Business               
Colby College               1980 – 1984               Kevin P Starr has a Bs/ba, in Mathematics, Business               
Colby College               1980 – 1984               Kevin P Starr has a Bs/ba, Mathematics, Business in Mathematics               
Belmont High School               1976 – 1980                              


Kevin P Starr's Professional Information
Information regarding Kevin P Starr's professional history.  Find out previous places Kevin P Starr has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Kevin P Starr Has Worked at 20 Places
Company: Alnylam Pharmaceuticals , Inc.
               Title: Committee Member
Company: Biogen Idec Inc.
               Title: Chief Financial Officer
Kevin P Starr's Experience
Title: Committee Member
               Company: Alnylam Pharmaceuticals , Inc.
Job Details
               Company Size: $50 mil to less than $100 mil - Employee Range: 100 to less than 500
Title: Chief Financial Officer
               Company: Biogen Idec Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000
Additional Professional Information on Kevin P Starr

 See Kevin P Starr's LinkedIn Profile



Kevin P Starr's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Kevin P Starr


Kevin P Starr's known Social Networks And Potential Email Matches

Find all of Kevin P Starr's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Kevin Starr
Username Matches

                  KevinStarr
                  StarrKevin
                  Kevin.Starr
                  Starr.Kevin
                  Kevin_Starr
                  Starr_Kevin
                  Kevin-Starr
                  Starr-Kevin
                  KStarr
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
K Starr







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














Insider Trading - Starr Kevin P - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Starr Kevin P





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-19Sale
2016-12-216:44 pm
Blueprint Medicines Corp
BPMC
Starr Kevin P10% Owner
106,489
$28.19
$3,002,351
5,453,753(IndirectDirect)
View


2016-12-16Sale
2016-12-205:46 pm
Global Blood Therapeutics Inc.
GBT
Starr Kevin P10% Owner
108,955
$16
$1,743,345
7,475,191(IndirectDirect)
View


2016-11-14Sale
2016-11-164:12 pm
Global Blood Therapeutics Inc.
GBT
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCThird Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JTepper Robert IStarr Kevin P10% Owner
2,000,000
$19.36
$38,720,001
9,475,191(Direct)
View


2016-09-06Sale
2016-09-074:05 pm
Editas Medicine Inc.
EDIT
Starr Kevin P10% Owner
5,890
$15.9
$93,666
3,906,176(IndirectDirect)
View


2016-05-16Sale
2016-05-184:24 pm
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
850,000
$31.25
$26,562,500
3,892,916(DirectIndirect)
View


2015-11-11Sale
2015-11-134:36 pm
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
75,000
$103.9
$7,792,118
37,500(Direct)
View


2015-09-24Sale
2015-09-254:38 pm
Zafgen Inc
ZFGN
Starr Kevin PDirector
136,579
$43.9
$5,995,403
476,170(IndirectDirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-19Other
2016-12-215:49 pm
N/AN/A
Voyager Therapeutics Inc.
VYGR
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCStarr Kevin PTepper Robert I10% Owner
750,000
$0
10,311,176(Direct)
View


2016-12-14Other
2016-12-164:06 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Third Rock Ventures II L.P.Starr Kevin PThird Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JTepper Robert I10% Owner
2,000,000
$0
7,475,191(Direct)
View


2016-11-29Other
2016-12-015:28 pm
N/AN/A
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
850,000
$0
8,537,754(Indirect)
View


2016-11-07Other
2016-11-094:05 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
1,000,000
$0
7,670,348(Direct)
View


2016-11-03Other
2016-11-075:57 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JTepper Robert IStarr Kevin P10% Owner
2,000,000
$0
10,475,191(Direct)
View


2016-08-19Other
2016-08-194:16 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
1,000,000
$0
2,892,916(Indirect)
View


2016-08-16Other
2016-08-164:15 pm
N/AN/A
Editas Medicine Inc.
EDIT
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
750,000
$0
3,906,176(Direct)
View


2016-06-22Option Award
2016-06-2411:34 am
N/A2026-06-22
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
13,922
$28.35
13,922(Direct)
View


2016-06-07Option Award
2016-06-096:27 pm
N/A2026-06-06
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
11,000
$13.6
11,000(Direct)
View


2016-06-03Option Award
2016-06-074:51 pm
2017-06-032026-06-03
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
11,250
$70.2
11,250(Direct)
View


2016-04-14Other
2016-04-155:51 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
1,200,000
$0
5,453,753(Direct)
View


2016-02-08Conversion
2016-02-085:18 pm
N/AN/A
Editas Medicine Inc.
EDIT
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
4,656,176
$0
4,656,176(Direct)
View


2016-02-08Conversion
2016-02-085:18 pm
N/AN/A
Editas Medicine Inc.
EDIT
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
6,628,542
$0
4,656,176(Direct)
View


2016-02-08Conversion
2016-02-085:18 pm
N/AN/A
Editas Medicine Inc.
EDIT
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
5,255,300
$0
4,656,176(Direct)
View


2016-02-08Conversion
2016-02-085:18 pm
N/AN/A
Editas Medicine Inc.
EDIT
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
222,222
$0
4,656,176(Direct)
View


2015-11-16Conversion
2015-11-184:33 pm
N/AN/A
Voyager Therapeutics Inc.
VYGR
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCStarr Kevin PTepper Robert I10% Owner
10,588,235
$0
11,061,176(Direct)
View


2015-11-16Conversion
2015-11-184:33 pm
N/AN/A
Voyager Therapeutics Inc.
VYGR
Third Rock Ventures III L.P.Third Rock Ventures Gp III L.P.Trv Gp III LLCStarr Kevin PTepper Robert I10% Owner
45,000,000
$0
11,061,176(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
739,306
$0
6,653,753(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
220,387
$0
6,653,753(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
220,387
$0
6,653,753(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
40,290
$0
6,653,753(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
40,290
$0
6,653,753(Direct)
View


2015-11-18Other
2015-11-184:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
40,290
$0
6,653,753(Direct)
View


2015-11-12Other
2015-11-134:46 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
1,700,000
$0
4,742,916(Indirect)
View


2015-11-12Other
2015-11-134:46 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
109,832
$0
4,742,916(Indirect)
View


2015-11-12Other
2015-11-134:46 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
109,832
$0
4,742,916(Indirect)
View


2015-11-12Other
2015-11-134:46 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
15,986
$0
4,742,916(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
N/AN/A
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
25,000
$9.3
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
N/AN/A
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
12,500
$11.33
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
N/AN/A
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
12,500
$11.33
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
N/AN/A
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
25,000
$15.82
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
2013-06-212022-06-21
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
12,500
$11.33
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
2013-06-212022-06-21
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
12,500
$11.33
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
2011-06-022020-06-02
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
25,000
$15.82
37,500(Direct)
View


2015-11-11Exercise
2015-11-134:36 pm
2012-06-092021-06-09
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
25,000
$9.3
37,500(Direct)
View


2015-11-03Conversion
2015-11-054:30 pm
N/AN/A
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
8,843,537
$0
9,387,754(Indirect)
View


2015-11-03Conversion
2015-11-054:30 pm
N/AN/A
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
1,496,598
$0
9,387,754(Indirect)
View


2015-11-03Conversion
2015-11-054:30 pm
N/AN/A
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
32,500,000
$0
9,387,754(Indirect)
View


2015-11-03Conversion
2015-11-054:30 pm
N/AN/A
Myokardia Inc
MYOK
Starr Kevin PDirector10% Owner
5,500,000
$0
9,387,754(Indirect)
View


2015-10-14Conversion
2015-10-237:15 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
8,670,351
$0
8,670,351(Direct)
View


2015-10-14Conversion
2015-10-237:15 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
8,105,314
$0
8,670,351(Direct)
View


2015-10-14Conversion
2015-10-237:15 pm
N/AN/A
Cytomx Therapeutics Inc.
CTMX
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
565,037
$0
8,670,351(Direct)
View


2015-09-24Other
2015-09-254:38 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector
1,655,095
$0
476,170(Indirect)
View


2015-09-24Other
2015-09-254:38 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector
476,170
$0
476,170(Indirect)
View


2015-09-24Other
2015-09-254:38 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector
476,170
$0
476,170(Indirect)
View


2015-09-24Other
2015-09-254:38 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector
98,834
$0
476,170(Direct)
View


2015-08-17Conversion
2015-08-194:34 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Starr Kevin PDirector10% Owner
11,903,763
$0
12,475,191(Indirect)
View


2015-08-17Conversion
2015-08-194:34 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Starr Kevin PDirector10% Owner
2,285,713
$0
12,475,191(Indirect)
View


2015-08-17Conversion
2015-08-194:34 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Starr Kevin PDirector10% Owner
41,663,168
$0
12,475,191(Indirect)
View


2015-08-17Conversion
2015-08-194:34 pm
N/AN/A
Global Blood Therapeutics Inc.
GBT
Starr Kevin PDirector10% Owner
8,000,000
$0
12,475,191(Indirect)
View


2015-08-18Other
2015-08-184:33 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
2,330,157
$0
6,442,916(Indirect)
View


2015-08-18Other
2015-08-184:33 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
150,546
$0
6,442,916(Indirect)
View


2015-08-18Other
2015-08-184:33 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
150,546
$0
6,442,916(Indirect)
View


2015-08-18Other
2015-08-184:33 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
21,910
$0
6,442,916(Direct)
View


2015-08-11Option Award
2015-08-133:46 pm
N/A2025-08-10
Global Blood Therapeutics Inc.
GBT
Starr Kevin PDirector
15,000
$20
15,000(Direct)
View


2015-07-23Other
2015-07-244:37 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
1,200,000
$0
2,002,045(Indirect)
View


2015-07-23Other
2015-07-244:37 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
479,081
$0
2,002,045(Indirect)
View


2015-07-23Other
2015-07-244:37 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
479,081
$0
2,002,045(Indirect)
View


2015-07-23Other
2015-07-244:37 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
99,351
$0
2,002,045(Direct)
View


2015-07-13Option Award
2015-07-156:33 pm
N/A2025-07-13
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
12,000
$37.15
12,000(Direct)
View


2015-06-19Other
2015-06-224:34 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
1,000,000
$0
8,773,073(Indirect)
View


2015-06-19Other
2015-06-224:34 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
64,607
$0
8,773,073(Indirect)
View


2015-06-19Other
2015-06-224:34 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
64,607
$0
8,773,073(Indirect)
View


2015-06-19Other
2015-06-224:34 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
9,403
$0
8,773,073(Direct)
View


2015-06-01Option Award
2015-06-034:50 pm
2016-06-012025-06-01
Alnylam Pharmaceuticals Inc
ALNY
Starr Kevin PDirector
11,250
$131.2
11,250(Direct)
View


2015-05-28Option Award
2015-05-296:08 pm
N/A2025-05-28
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
13,922
$73.13
13,922(Direct)
View


2015-05-15Other
2015-05-1812:05 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
1,000,000
$0
3,202,045(Indirect)
View


2015-05-15Other
2015-05-1812:05 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
443,935
$0
3,202,045(Indirect)
View


2015-05-15Other
2015-05-1812:05 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
443,935
$0
3,202,045(Indirect)
View


2015-05-15Other
2015-05-1812:05 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
92,041
$0
3,202,045(Direct)
View


2015-05-14Other
2015-05-152:07 pm
N/AN/A
Foundation Medicine Inc.
FMI
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
828,456
$0
312,498(Direct)
View


2015-05-14Other
2015-05-152:07 pm
N/AN/A
Foundation Medicine Inc.
FMI
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
312,498
$0
312,498(Direct)
View


2015-05-14Other
2015-05-152:07 pm
N/AN/A
Foundation Medicine Inc.
FMI
Third Rock Ventures LpThird Rock Ventures Gp L.P.Trv Gp LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
312,498
$0
312,498(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
5,454,545
$0
7,393,059(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
1,424,242
$0
7,393,059(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
241,545
$0
7,393,059(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
30,000,000
$0
7,393,059(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
7,833,333
$0
7,393,059(Direct)
View


2015-05-05Conversion
2015-05-124:32 pm
N/AN/A
Blueprint Medicines Corp
BPMC
Third Rock Ventures II L.P.Third Rock Ventures Gp II L.P.Trv Gp II LLCLevin Mark JStarr Kevin PTepper Robert I10% Owner
1,328,502
$0
7,393,059(Direct)
View


2015-03-24Other
2015-03-252:20 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
1,400,000
$0
4,202,045(Indirect)
View


2015-03-24Other
2015-03-252:20 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
346,658
$0
4,202,045(Indirect)
View


2015-03-24Other
2015-03-252:20 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
346,658
$0
4,202,045(Indirect)
View


2015-03-24Other
2015-03-252:20 pm
N/AN/A
Zafgen Inc
ZFGN
Starr Kevin PDirector10% Owner
71,989
$0
4,202,045(Direct)
View


2015-02-19Other
2015-02-197:01 pm
N/AN/A
Agios Pharmaceuticals Inc
AGIO
Starr Kevin PDirector10% Owner
3,070,090
$0
760,195(Indirect)
View


2015-02-19Other
2015-02-197:01 pm
N/AN/A
Agios Pharmaceuticals Inc
AGIO
Starr Kevin PDirector10% Owner
760,195
$0
760,195(Indirect)
View


2015-02-19Other
2015-02-197:01 pm
N/AN/A
Agios Pharmaceuticals Inc
AGIO
Starr Kevin PDirector10% Owner
760,195
$0
760,195(Indirect)
View


2015-02-19Other
2015-02-197:01 pm
N/AN/A
Agios Pharmaceuticals Inc
AGIO
Starr Kevin PDirector10% Owner
157,867
$0
760,195(Direct)
View


2015-01-27Other
2015-01-285:31 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
1,255,177
$0
9,773,073(Indirect)
View


2015-01-27Other
2015-01-285:31 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
81,094
$0
9,773,073(Indirect)
View


2015-01-27Other
2015-01-285:31 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
81,094
$0
9,773,073(Indirect)
View


2015-01-27Other
2015-01-285:31 pm
N/AN/A
Sage Therapeutics Inc.
SAGE
Starr Kevin PDirector10% Owner
11,804
$0
9,773,073(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 23:50:24 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  


















Starr Kevin P - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1192603 - Address: C/o Third Rock Ventures, Llc,, 29 Newbury Street, 3Rd Floor, Boston, MA 02116 12 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret719-2-4-71530137S%wins78895038335056 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



4/14/17 16:004/12/17CTMXCytomx Therapeutics, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMATS-46416.369-28-15,202D1519371-12-11-6-22
12/21/16 18:4412/19/16BPMCBlueprint Medicines CorpDEHealthDrugPharmaceutical PreparationsStarr Kevin PMATS-3,00228.1913-106-25,454D1654-1-2-277-5-11344
12/20/16 17:4612/16/16GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsStarr Kevin PMATS-1,74316.0012-109-18,843D-47-10-30-3-14-10-6-113135
9/7/16 16:059/6/16EDITEditas Medicine, Inc.DEHealthBioPrdBiological Products, (No DiagStarr Kevin PMATS-9415.907-603,906D-62-52-41-20-13-54-7-7-533
5/18/16 16:245/16/16SAGESage Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsStarr Kevin PMADTS-26,56331.2514-850-183,958I-46-27-6-15-13-61-4-3-81472
11/13/15 16:3611/11/15ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADM.dm91112.1533750D83-1-17-619246-9-10-14-39-49-57
11/13/15 16:3611/11/15ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADS.dm-7,792103.9033-75-1000D83-1-17-619246-9-10-14-39-49-57
9/25/15 16:389/24/15ZFGNZafgen, Inc.DEHealthDrugPharmaceutical PreparationsStarr Kevin PMADS-5,99543.9011-137-27370M105-21311101-8-8-12-65-73-76-82
9/26/14 16:319/24/14ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADM.dm1,51616.8533900D2952319211619600-41919336
9/26/14 16:319/24/14ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADS.dm-7,02878.0933-90-1000D2952319211619600-41919336
3/26/13 18:533/25/13ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADM.dm500.950011530D1401061926-4-7-6-320125168184
3/26/13 18:533/25/13ALNYAlnylam Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsStarr Kevin PMADS.dm-1,23623.4911-53-1000D1401061926-4-7-6-320125168184



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.







STARR KEVIN P Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      STARR KEVIN P
                    

•   CAMBRIDGE, MA
                      
How do I update this listing?




                                             Starr Kevin P is based out of Cambridge.    WhaleWisdom has at least 5 insider transactions (Form 3,4,5) in our database for Starr Kevin P. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from STARR KEVIN P, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




starr kevin p


75 SIDNEY STREET

CAMBRIDGE
MA
                                                        
                                                    02139


                                                      Business Phone:
                                                      617-299-8380
SEC SIC CODE:2834-PHARMACEUTICAL PREPARATIONS







Recent SEC Filings




4 filed on 07/19/2017
4 filed on 07/13/2017
4 filed on 06/16/2017
4 filed on 06/16/2017
4 filed on 06/09/2017
4 filed on 06/06/2017
4 filed on 05/19/2017
4 filed on 04/14/2017
4 filed on 04/14/2017
4 filed on 04/06/2017
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



















Global Insurance & Investments | STARR









































United States  English
US / EN



中国 - 中文


日本-日本語


United Kingdom  English




Search


Menu










Homepage


Who We Are


Starr Insurance


Investments


Client Services


News


Careers




Executive Intelligence Services at STARR


Starr Insure - Small Business Online Solutions


China Desk - Partner with a global organization


Contact Us


Global Offices
















United States  English
US / EN



中国 - 中文


日本-日本語


United Kingdom  English




Search


Menu










The over and above underwriter.
At Starr, insurance is not just something we do - it’s who we are.
















Starr Insurance
EXPLORE SOLUTIONS


Select


Accident & Health Overview


Aircraft Hull & Liability


Auto Liability


Auto Liability - Commercial General Casualty


Aviation Products & Completed Operations Liability


Aviation General Liability


Aviation and Aerospace Overview 


Aviation Workers’ Compensation


Blanket Accident/Liability & Special Risks


Boiler & Machinery


Business Interruption


Commercial General Casualty Overview 


Contaminated Products


Construction Overview 


Cyber Overview 


Cyber & Terror Response 


Crisis Management Overview 


Contractor Pollution


Commercial Multi-Line StarrBOP


Crime & Fidelity


Critical Illness


Defense Base Act Overview 


Directors & Officers


Employment Practice Liability


Environmental General Liability


Environmental Overview 


Energy Overview


Errors & Omissions / Professional Liability


Excess Construction


Excess Casualty


Facultative Reinsurance of Memorandums of Coverage


Fiduciary


Financial Lines Overview


Follow Form Excess


Follow Form Excess - Public Entity


General Liability - Commercial General Casualty


Group and Individual AD&D


Hull


Inland Marine


Kidnap, Ransom & Extortion


Leisure Travel


Marine Liability


Marine Overview


National Accounts Excess Energy Liability


Ocean Cargo


Political Risk


Primary Construction


Primary & Excess Energy Liability


Primary General Liability


Product Recall


Professional Liability Overview 


Professional Liability for Environmental Consultants


Programs


Property Overview 


Property Damage


Public Entity Overview 


Retained Limit Form


Risk Management General Casualty Overview 


Security & Privacy Risk Response


Site Pollution


Small Business Solutions For Brokers


Space


Sports and Special Events


Statutory 


Travel Accident


Workers’ Compensation & Employer’s Liability - Commercial General Casualty


Workers’ Compensation & Employer’s Liability








Who We Are
OUR APPROACH


Global Offices






Client Services
LEARN MORE


Select

Report a Claim
Executive Intelligence Services at STARR
STARR Strategic Partners
Risk Management Services
Safety & Loss Control Services









Connect with us








 







Intelligence Consulting Services
Executive Intelligence Brief







 
7/19/2017
Starr Companies Partners with CoverWallet to Develop New Online Insurance P...












@StarrCompanies











2d

Starr Companies

@StarrCompanies


@DMariePT Thank you for the RT!
                                    








2d

Starr Companies

@StarrCompanies


@bjkbrady Thank you for the RT!
                                    








2d

Starr Companies

@StarrCompanies


                                        RT @StarrCompanies: #Travel

If you are traveling locally & using a rental car, Starr Assist can cover potential damages to your vehicle ht…
                                    















Cyber
Cyber Overview 









Accident and Health
Group and Individual AD&D









White Papers
Breaking Ground










A.M. Best Financial Strength Rating





Starr Indemnity & Liability Company holds an A.M. Best financial strength rating of "A" (Excellent), Financial Size Category XIV, and an issuer credit rating of "a."
Starr Syndicate Limited at Lloyd's of London holds an A.M. Best financial strength rating of "A" (Excellent), Financial Size Category XV, and a Standard & Poor's rating of "A+" (Strong) (Lloyd's of London market ratings).
Effective Date: May 23, 2017


Starr Surplus Lines Insurance Company holds an A.M. Best financial strength rating of "A" (Excellent), Financial Size Category XV, and an issuer credit rating of "a."
Starr International Insurance (Asia) Ltd. holds an A.M. Best financial strength rating of “A” (Excellent), Financial Size Category XV an issuer credit rating of “a.”
Starr Insurance & Reinsurance Limited holds an A.M. Best financial strength rating of “A” (Excellent), Financial Size Category XV, and an issuer credit rating of “a.”




 






